Janus Henderson Group
MYOK

Janus Henderson Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Janus Henderson Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-723,989
Closed -$98.7M – 1459
2020
Q3 		$98.7M Sell
723,989
-459,647
-39% -$48.9M 0.05% 333
2020
Q2 		$114M Sell
1,183,636
-341,245
-22% -$28.5M 0.06% 286
2020
Q1 		$71.5M Buy
1,524,881
+500,462
+49% +$32.1M 0.05% 359
2019
Q4 		$74.7M Buy
+1,024,419
New +$62.1M 0.04% 467

Janus Henderson Group's MYOK Position: Q4 2020 in Review

Janus Henderson Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 723,989 shares — an estimated $98.7M sold.

Janus Henderson Group first reported a position in MYOK in Q4 2019 and held it in 4 quarters. The position peaked at $114M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Janus Henderson Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Janus Henderson Group sold 723,989 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $98.7M.
  • Janus Henderson Group first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Janus Henderson Group's MyoKardia, Inc. Common Stock position peaked at $114M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Janus Henderson Group's 13F filing for Q4 2020, filed 16 Feb 2021.